pargyline has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, C; Dai, L; Peng, YP; Qiu, YH | 1 |
Jiang, JL; Peng, YP; Qiu, YH; Wang, JJ | 1 |
2 other study(ies) available for pargyline and concanavalin a
Article | Year |
---|---|
Effect of endogenous catecholamines in lymphocytes on lymphocyte function.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-Methyltyrosine; Analysis of Variance; Animals; Blotting, Northern; Catecholamines; Cell Proliferation; Cells, Cultured; Chromatography, High Pressure Liquid; Concanavalin A; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Enzyme Inhibitors; Lymphocyte Activation; Lymphocytes; Pargyline; Phentolamine; Propranolol; Radioimmunoassay; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tyrosine 3-Monooxygenase | 2005 |
Effect of endogenous catecholamines on apoptosis of Con A-activated lymphocytes of rats.
Topics: alpha-Methyltyrosine; Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catecholamines; Cells, Cultured; Concanavalin A; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Flow Cytometry; Gene Expression Regulation; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Mitogens; Pargyline; Proto-Oncogene Proteins c-bcl-2; Rats | 2007 |